Lung transplantation can be a life-saving procedure for those with end-stage lung diseases.
Unfortunately, long term graft and patient survival are limited by both acute and chronic …

Lung transplantation is a therapeutic option for patients with end-stage pulmonary disorders.
Unfortunately, due to post–lung transplant complications, both infectious and noninfectious …

Advances in maintenance immunosuppression over the past three decades have improved
solid organ transplantation outcomes dramatically. Uninterrupted access to …

Background Alterations in the respiratory microbiome are common in chronic lung diseases,
correlate with decreased lung function, and have been associated with disease progression …

Rationale: The subjective perception of dyspnea, which is an impairing symptom in various
cardiopulmonary diseases, consists of sensory (intensity) and affective aspects …

BACKGROUND Lung transplant (LTx) recipients have low long-term survival and a high
incidence of bronchiolitis obliterans syndrome (BOS). However, few long-term, multicenter …

Donor-specific HLA antibodies (DSA) have an adverse effect on short-term and long-term
lung transplant outcomes. We implemented a perioperative strategy to treat DSA-positive …

Rationale: Severe and recurrent acute vascular rejection of the pulmonary allograft is an
accepted major risk factor for obliterative bronchiolitis. Objectives: We assessed the role of …

Lung transplantation is a therapeutic option for patients with end-stage pulmonary disorders.
Unfortunately, chronic lung allograft dysfunction (CLAD), most commonly manifest as …

BACKGROUND: Chronic lung allograft dysfunction, which manifests as bronchiolitis
obliterans syndrome (BOS), is recognized as the primary cause of morbidity and mortality …